CNS clinical trials [[electronic resource] ] : suicidality and data collection : workshop summary / / Sarah Hanson, Miriam Davis, and Bruce Altevogt ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy
(Visualizza in formato marc)
(Visualizza in BIBFRAME)
| Autore: |
Hanson Sarah
|
| Titolo: |
CNS clinical trials [[electronic resource] ] : suicidality and data collection : workshop summary / / Sarah Hanson, Miriam Davis, and Bruce Altevogt ; Forum on Neuroscience and Nervous System Disorders, Board on Health Sciences Policy
|
| Pubblicazione: | Washington, D.C., : National Academies Press, 2010 |
| Descrizione fisica: | xii, 75 p |
| Disciplina: | 616.85/8445 |
| Soggetto topico: | Suicide - Risk factors |
| Suicide - Prevention | |
| Altri autori: |
DavisMiriam
AltevogtBruce M
|
| Note generali: | Bibliographic Level Mode of Issuance: Monograph |
| Nota di contenuto: | Perspectives from the FDA, academia, and patients -- Data collection and optimization -- Data analysis -- Partnerships, opportunities, collaboration. |
| Sommario/riassunto: | "The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future."--Publisher's description. |
| Titolo autorizzato: | CNS clinical trials |
| ISBN: | 0-309-18648-X |
| 1-282-97591-9 | |
| 9786612975912 | |
| 0-309-14884-7 | |
| Formato: | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione: | Inglese |
| Record Nr.: | 9910781003703321 |
| Lo trovi qui: | Univ. Federico II |
| Opac: | Controlla la disponibilità qui |